Search results:
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Fluoride (sodium) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A01. Stomatological preparations | — | New Zealand | OTC | — |
| Hexetidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A01. Stomatological preparations | — | New Zealand | OTC | External use. |
| Aluminium hydroxide | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | General sale. |
| Calcium carbonate | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | — |
| Carbenoxolone | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | General sale. External use only. |
| Cetraxate | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | N.R. | Not registered or not marketed. |
| Cimetidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 1994 | New Zealand | OTC | — |
| Famotidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | — |
| Lansoprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 2010 | New Zealand | OTC | Lansoprazole was switched from prescription to pharmacist-only status in 2010, in tablets or capsules containing 15 milligrams or less when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine. |
| Nizatidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | — |
| Omeprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 2010 | New Zealand | OTC | In November 2010 omeprazole, in tablets containing 20mg or less of omeprazole, with a maximum daily dose of 20mg of omeprazole in a pack size of up to 14 dosage units, was reclassified from 'restricted medicine' to 'pharmacy-only medicine' for the short-term, symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine. Medsafe should update the New Zealand Regulatory Guide-lines to reflect this recommendation and ensure that the warnings statements for omeprazole read "consult a pharmacist or doctor". |
| Pantoprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 2009 | New Zealand | OTC | Pantoprazole was switched in 2009 from prescription-only to S3 pharmacist-only status in tablets or capsules containing 20 milligrams or less of pantoprazole when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine. |
| Rabeprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | N.R. | Not registered or not marketed. |
| Ranitidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | — |
| Sucralfate | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | — | New Zealand | OTC | — |
| Dicyclomine (Dicycloverine) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | Rx | — |
| Dimeticone | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | OTC | — |
| Domperidone | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | Rx | — |
| Hyoscine butylbromide | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | OTC | — |
| Mebeverine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | Rx | — |
| Metoclopramide | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | OTC | Pharmacist only medicines in combination with paracetamol for treatment of nausea associated with migraine. |
| Propantheline | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | New Zealand | OTC | — |
| Dimenhydrinate (diphenhydramine and 8-chlorotheophylline) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A04. Antiemetics and antinauseants | — | New Zealand | OTC | Pharmacy-only for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults or children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft. Pharmacist-only for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule. |
| Hyoscine (Scopolamine) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A04. Antiemetics and antinauseants | — | New Zealand | OTC | — |
| Hymecromone | A Alimentary tract and metabolism. Alimentary tract and metabolism | A05. Bile and liver therapy | — | New Zealand | N.R. | Not registered or not marketed. |
| Bisacodyl | A Alimentary tract and metabolism. Alimentary tract and metabolism | A06. Laxatives | — | New Zealand | OTC | — |
| Lactitol | A Alimentary tract and metabolism. Alimentary tract and metabolism | A06. Laxatives | — | New Zealand | N.R. | Not registered or not marketed. |
| Lactulose | A Alimentary tract and metabolism. Alimentary tract and metabolism | A06. Laxatives | — | New Zealand | OTC | — |
| Macrogol (Polyethylene glycol 3350) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A06. Laxatives | — | New Zealand | OTC | Restricted (in oral preparations for bowel cleansing prior to diagnostic, medical or surgical procedures). |
| Picosulfate (sodium) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A06. Laxatives | — | New Zealand | OTC | — |
| Loperamide | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | — | New Zealand | OTC | Loperamide is a pharmacy-only medicine in packs containing not more than 20 tablets or capsules. It is on general sale since July 2010 in divided solid dosage forms for oral use containing 2 milligrams or less of loperamide per dosage form when sold in a pack containing not more than eight dosage forms approved by the Minister or the Director-General for distribution as a general sale medicine for the symptomatic treatment of acute non specific diarrhoea. |
| Nifuroxazide | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | — | New Zealand | N.R. | Not registered or not marketed. |
| Orlistat | A Alimentary tract and metabolism. Alimentary tract and metabolism | A08. Antiobesity preparations | 2005 | New Zealand | OTC | Pharmacist only. Consumer advertising permitted. |
| Vitamin A (Retinol) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A11. Vitamins | — | New Zealand | OTC | — |
| Selenium | A Alimentary tract and metabolism. Alimentary tract and metabolism | A12. Mineral supplements | — | New Zealand | OTC | — |
| Tranexamic acid | B Blood and blood forming organs. Blood and blood forming organs | B02. Antihemorrhagics | — | New Zealand | Rx | — |
| Adenosine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | New Zealand | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | New Zealand | OTC | Pharmacist only medicine for oral, sublingual or rectal use. |
| Ubidecarenone | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | New Zealand | N.R. | Not registered or not marketed. |
| Lovastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | New Zealand | N.R. | Not registered or not marketed. |
| Simvastatin | C Cardiovascular system. Cardiovascular system | C10. Lipid modifying agents | — | New Zealand | Rx | — |
| Amorolfine (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | OTC | March 1999, S4 to S3 switch in topical preparations containing 5% or less for the treatment of onychomycoses. March 2000, all amorolfine preparations for topical use switched from S4 to S3, except for preparations containing 0.25% or less (S4 to S2). September 2006, S2 to GSL switch for preparations for treatment of tinea pedis. |
| Bifonazole | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | OTC | Extended to General Sale for tinea pedis only (July 1999). |
| Butenafine | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | N.R. | Not registered or not marketed. |
| Ciclopirox Olamine | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | OTC | Extended to General Sale for tinea pedis only (July 1999). |
| Clotrimazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | OTC | Extended to General Sale for tinea pedis only (July 1999). |
| Croconazole | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | N.R. | Not registered or not marketed. |
| Econazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | OTC | Extended to General Sale for tinea pedis only (July 1999). |
| Fenticonazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | N.R. | Not registered or not marketed. |
| Fluconazole | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | New Zealand | OTC | Pharmacist-only for 150mg or less as a single dose for the treatment of vaginal candidiasis. |
- Page 1 of 6
- Next
- 50 of 263 ingredients